Angelman syndrome (AS) is a rare genetic neurodevelopmental disorder that is often diagnosed incorrectly or late, even with advancements in molecular diagnostics. Approximately 1 in every 12,000 to 20,000 births is affected by this syndrome. On February 28, World Rare Disease Day is commemorated to raise awareness of less common conditions like AS, which have a substantial impact on healthcare and social dynamics. Many families facing this disorder undergo emotional challenges, given the complexity of the condition.

Despite the progress in diagnosing Angelman syndrome, statistics indicate that around 50% of individuals receive an initial misdiagnosis, and over 70% experience delays of at least one year before obtaining the correct diagnosis. This highlights significant gaps in healthcare awareness and education regarding rare genetic disorders, as conditions like AS can share symptoms with other neurodevelopmental issues, leading to confusion in diagnosis. Raising awareness through events like World Rare Disease Day can play a crucial role in improving the understanding of these conditions within the medical community and society as a whole.

The implications for families affected by Angelman syndrome are profound, as the disorder not only affects the individuals but also the emotional and social well-being of their families. With better awareness and understanding of AS, healthcare professionals can improve diagnosis accuracy and provide timely interventions, significantly impacting the quality of life for those affected and their loved ones. Thus, continuing education and research into rare disorders remain essential to support affected individuals and their families.